» Articles » PMID: 39030557

Current Understanding of Functional Peptides Encoded by LncRNA in Cancer

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2024 Jul 19
PMID 39030557
Authors
Affiliations
Soon will be listed here.
Abstract

Dysregulated gene expression and imbalance of transcriptional regulation are typical features of cancer. RNA always plays a key role in these processes. Human transcripts contain many RNAs without long open reading frames (ORF, > 100 aa) and that are more than 200 bp in length. They are usually regarded as long non-coding RNA (lncRNA) which play an important role in cancer regulation, including chromatin remodeling, transcriptional regulation, translational regulation and as miRNA sponges. With the advancement of ribosome profiling and sequencing technologies, increasing research evidence revealed that some ORFs in lncRNA can also encode peptides and participate in the regulation of multiple organ tumors, which undoubtedly opens a new chapter in the field of lncRNA and oncology research. In this review, we discuss the biological function of lncRNA in tumors, the current methods to evaluate their coding potential and the role of functional small peptides encoded by lncRNA in cancers. Investigating the small peptides encoded by lncRNA and understanding the regulatory mechanisms of these functional peptides may contribute to a deeper understanding of cancer and the development of new targeted anticancer therapies.

Citing Articles

Noncoding RNA-encoded peptides in cancer: biological functions, posttranslational modifications and therapeutic potential.

Tan S, Yang W, Ren Z, Peng Q, Xu X, Jiang X J Hematol Oncol. 2025; 18(1):20.

PMID: 39972384 PMC: 11841355. DOI: 10.1186/s13045-025-01671-9.


Role of non-coding RNAs in the pathogenesis of viral myocarditis.

Kang Z, Zhang L, Yang Z Virulence. 2025; 16(1):2466480.

PMID: 39950847 PMC: 11849450. DOI: 10.1080/21505594.2025.2466480.


Unlocking the secrets of the immunopeptidome: MHC molecules, ncRNA peptides, and vesicles in immune response.

Balakrishnan A, Winiarek G, Holowka O, Godlewski J, Bronisz A Front Immunol. 2025; 16:1540431.

PMID: 39944685 PMC: 11814183. DOI: 10.3389/fimmu.2025.1540431.


Role of long noncoding RNAs in the regulation of epithelial‑mesenchymal transition in osteosarcoma (Review).

Li Z, Tian Y Oncol Rep. 2025; 53(3).

PMID: 39930817 PMC: 11783035. DOI: 10.3892/or.2025.8868.


Diagnostic and Therapeutic Advances of RNAs in Precision Medicine of Gastrointestinal Tumors.

Liu R, Zhou J, Chen X, Zhang J, Chen Q, Liu X Biomedicines. 2025; 13(1).

PMID: 39857631 PMC: 11762367. DOI: 10.3390/biomedicines13010047.


References
1.
Xu W, Deng B, Lin P, Liu C, Li B, Huang Q . Ribosome profiling analysis identified a KRAS-interacting microprotein that represses oncogenic signaling in hepatocellular carcinoma cells. Sci China Life Sci. 2019; 63(4):529-542. DOI: 10.1007/s11427-019-9580-5. View

2.
Zhang Y, Wang X, Hu C, Yi H . Shiny transcriptional junk: lncRNA-derived peptides in cancers and immune responses. Life Sci. 2023; 316:121434. DOI: 10.1016/j.lfs.2023.121434. View

3.
Lin J, Lai E . Protein-Protein Interactions: Co-Immunoprecipitation. Methods Mol Biol. 2017; 1615:211-219. DOI: 10.1007/978-1-4939-7033-9_17. View

4.
Zhang Y, Zhu Z, Huang S, Zhao Q, Huang C, Tang Y . lncRNA XIST regulates proliferation and migration of hepatocellular carcinoma cells by acting as miR-497-5p molecular sponge and targeting PDCD4. Cancer Cell Int. 2019; 19:198. PMC: 6664491. DOI: 10.1186/s12935-019-0909-8. View

5.
Huang J, Chen M, Chen D, Gao X, Zhu S, Huang H . A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. Mol Cell. 2017; 68(1):171-184.e6. DOI: 10.1016/j.molcel.2017.09.015. View